EGFR mutations in non-small-cell lung cancer reply

被引：0
|
作者：
Mitsudomi, Tetsuya [1 ]
Yatabe, Yasushi [1 ]
机构：
[1] Aichi Canc Ctr Hosp, Nagoya, Aichi 464, Japan
来源：
LANCET ONCOLOGY | 2010年 / 11卷 / 05期
关键词：
FACTOR-RECEPTOR GENE; METASTASES;
D O I：
10.1016/S1470-2045(10)70075-9
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：413 / 413
页数：1
相关论文
共 50 条
  • [21] Potential Usage of Afanitib in the Treatment of Non-Small-Cell Lung Cancer with Uncommon EGFR Mutations
    Harada, Taishi
    Yamaba, Yukiko
    Hayata, Hiroki
    Okuda, Takashi
    Kimura, Yoshishige
    Komaki, Toshiyuki
    Kagawa, Keizo
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S1241 - S1241
  • [22] Human Papillomavirus in Non-Small-Cell Lung Cancer: The Impact of EGFR Mutations and the Response to Erlotinib
    Marquez-Medina, Diego
    Gasol-Cudos, Ariadna
    Teresa Taberner-Bonastre, M.
    Samame Perez-Vargas, Juan Carlos
    Salud-Salvia, Antonieta
    Llombart-Cussac, Antonio
    [J]. ARCHIVOS DE BRONCONEUMOLOGIA, 2013, 49 (02): : 79 - 81
  • [23] Advanced non-small-cell Lung Cancer (NSCLC) Solid Options for EGFR-Mutations
    Roos, Martin
    [J]. ONCOLOGY RESEARCH AND TREATMENT, 2017, 40 (10) : 639 - 639
  • [24] Mutation-Specific Antibodies for the Detection of EGFR Mutations in Non-Small-Cell Lung Cancer
    Yu, J.
    Benedettini, E.
    Li, D. Q.
    Gu, T.
    Herebert, H.
    Smith, B.
    Polakiewicz, R.
    Zhou, X. M.
    Loda, M.
    Comb, M.
    [J]. MODERN PATHOLOGY, 2009, 22 : 364A - 364A
  • [25] Effectiveness of icotinib against non-small-cell lung cancer with uncommon EGFR mutations.
    Zhou, Shengyu
    Hu, Xingsheng
    Wang, Yan
    Li Junling
    Zhou, Liqiang
    Hao, Xuezhi
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [26] Mutation-Specific Antibodies for the Detection of EGFR Mutations in Non-Small-Cell Lung Cancer
    Yu, J.
    Benedettini, E.
    Li, D. Q.
    Gu, T.
    Herebert, H.
    Smith, B.
    Polakiewicz, R.
    Zhou, X. M.
    Loda, M.
    Comb, M.
    [J]. LABORATORY INVESTIGATION, 2009, 89 : 364A - 364A
  • [27] EGFR exon 20 insertion mutations and response to osimertinib in non-small-cell lung cancer
    Fang, Wenfeng
    Huang, Yihua
    Hong, Shaodong
    Zhang, Zhonghan
    Wang, Minghui
    Gan, Jiadi
    Wang, Wenjing
    Guo, Honglin
    Wang, Kai
    Zhang, Li
    [J]. BMC CANCER, 2019, 19 (1)
  • [28] Adagrasib in Non-Small-Cell Lung Cancer REPLY
    Janne, Pasi A.
    Sabari, Joshua K.
    Spira, Alexander I.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2022, 387 (13): : 1239 - 1239
  • [29] Nivolumab in non-small-cell lung cancer with EGFR mutation
    Yoshida, H.
    Kim, Y. H.
    Ozasa, H.
    Nagai, H.
    Sakamori, Y.
    Tsuji, T.
    Nomizo, T.
    Yasuda, Y.
    Funazo, T.
    Hirai, T.
    [J]. ANNALS OF ONCOLOGY, 2018, 29 (03) : 777 - 778
  • [30] FREQUENCY OF EGFR MUTATIONS IN NON-SMALL-CELL LUNG CANCER (NSCLC) FROM GREEK PATIENTS
    Papadopoulou, E.
    Murray, S.
    Efstathiadou, C.
    Nasioulas, G.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2012, 7 (06) : S35 - S36
12345